# Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity

Article · Sean Wharton, Ildiko Lingvay, Paweł Bogdański, Ruben Duque do Vale, Stephan Jacob, Tobias Karlsson, C. Shaji, Domenica Rubino, William Timothy Garvey

- Archive id: doi:10.1056/nejmoa2500969
- Published: 2025-09-17
- Venue: New England Journal of Medicine
- DOI: https://doi.org/10.1056/nejmoa2500969
- PMID: 40934115
- Citations: 140
- Source URL: https://doi.org/10.1056/nejmoa2500969
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

Cited in dossiers:
- [GLP-1 & Incretin Therapies: State of the Field (October 2026)](https://space-kitty.com/dossiers/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.